Clinic 1 — Dr. Zandi
90.4% of records have no CGM Outcome recorded. Data capture may need attention.
Detected: Current
12 patients have pending follow-ups. Timely outreach could improve conversion.
Detected: Current
Feb 2026 snapshot | 758 potentials tracked across the pilot
Potentials
311
Feb 2026
Conversions
11
Feb 2026
Conversion Rate
3.5%
Feb 2026
All-Time Potentials
758
All-Time Conversions
29
Referrals
570
Rx Conversion Rate
0%
OTC Conversion Rate
3.9%
Monthly and weekly trends with Rx/OTC breakdown
Latest growth: -19.6% from previous month
Text analysis of clinical notes and patient interactions
Most Common Notes
Actionable Follow-ups
Dr. Zandi's Analysis
90.4% of records have no CGM Outcome recorded. Data capture may need attention.
The "Diabetic Uncontrolled (8.1–10)" cohort has the highest conversion rate at 30% (3/10 patients).
3.8% overall conversion (29/758). Rx: 0% (20/0 potentials), OTC: 7% (9/129 potentials).
0 Rx potentials (on insulin), 129 OTC potentials (A1C 5.7–6.4, no insulin). More patients are OTC-eligible than Rx-eligible.
12 patients require follow-up. Timely outreach could convert these to active CGM users.
29 patients declined CGM. Top reasons: tech compatibility (15), patient readiness preference (10), cost insurance (4).
80 notes analyzed. Most common theme: "Existing CGM User" (20 notes). 15 actionable follow-up items identified.
Data completeness score is 64/100. Improving data capture on key fields would enhance analysis accuracy.